Emendo Biotherapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
100
- Latest Deal Type
-
M&A
Emendo Biotherapeutics General Information
Description
Developer of gene editing tools designed to resolve bottlenecks in gene therapy. The company engages in using protein engineering to bring disruptive protein processes to resolve the bottleneck in gene therapy, enabling physicians to address disorders and diseases that are currently considered to be untreatable.
Contact Information
Website
www.emendobio.com(Operating Subsidiary)
Corporate Office
- 111 Town Square Place
- Suite 1507
- Jersey City, NJ 07310
- United States
Corporate Office
- 111 Town Square Place
- Suite 1507
- Jersey City, NJ 07310
- United States
Emendo Biotherapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Dec-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series B) | 15-Jan-2020 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 05-Oct-2016 | $12M | $12M | Completed | Startup |
Emendo Biotherapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | ||||||||
| Series A1 | 943,279 | $0.000010 | $0.27 | $3.37 | $3.37 | 1x | $3.37 | 7.13% |
| Series A | 3,564,000 | $0.000010 | $0.18 | $2.25 | $2.25 | 1x | $2.25 | 26.95% |
Emendo Biotherapeutics Comparisons
Industry
Financing
Details
Emendo Biotherapeutics Competitors (5)
One of Emendo Biotherapeutics’s 5 competitors is BlueRock Therapeutics, a Formerly VC-backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| BlueRock Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Editas Medicine | Formerly VC-backed | Cambridge, MA | ||||
| Voyager Therapeutics | Formerly VC-backed | Lexington, MA | ||||
| Spark Therapeutics | Formerly VC-backed | Philadelphia, PA | ||||
| Beam Therapeutics | Formerly VC-backed | Cambridge, MA |
Emendo Biotherapeutics Patents
Emendo Biotherapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026231945-A1 | Biallelic knockout of bcl2l1 | Pending | 30-Apr-2025 | ||
| WO-2026231941-A1 | Biallelic knockout of parp1 | Pending | 30-Apr-2025 | ||
| WO-2026136519-A1 | Biallelic knockout of trbc 1/2 | Pending | 17-Dec-2024 | ||
| EP-4766832-A1 | Methods and compositions for modifying expression of a mutant transforming growth factor beta induced (tgfbi) allele | Pending | 23-Aug-2023 | ||
| WO-2025043140-A1 | Methods and compositions for modifying expression of a mutant transforming growth factor beta induced (tgfbi) allele | Inactive | 23-Aug-2023 | A61P27/02 |
Emendo Biotherapeutics Signals
Emendo Biotherapeutics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| OrbiMed | Growth/Expansion | Minority | ||
| Takeda Ventures | Corporate Venture Capital | Minority |
Emendo Biotherapeutics FAQs
-
When was Emendo Biotherapeutics founded?
Emendo Biotherapeutics was founded in 2015.
-
Where is Emendo Biotherapeutics headquartered?
Emendo Biotherapeutics is headquartered in Jersey City, NJ.
-
What is the size of Emendo Biotherapeutics?
Emendo Biotherapeutics has 100 total employees.
-
What industry is Emendo Biotherapeutics in?
Emendo Biotherapeutics’s primary industry is Discovery Tools (Healthcare).
-
Is Emendo Biotherapeutics a private or public company?
Emendo Biotherapeutics is a Private company.
-
What is Emendo Biotherapeutics’s current revenue?
The current revenue for Emendo Biotherapeutics is .
-
How much funding has Emendo Biotherapeutics raised over time?
Emendo Biotherapeutics has raised $73M.
-
Who are Emendo Biotherapeutics’s investors?
OrbiMed and Takeda Ventures have invested in Emendo Biotherapeutics.
-
Who are Emendo Biotherapeutics’s competitors?
BlueRock Therapeutics, Editas Medicine, Voyager Therapeutics, Spark Therapeutics, and Beam Therapeutics are competitors of Emendo Biotherapeutics.
-
When was Emendo Biotherapeutics acquired?
Emendo Biotherapeutics was acquired on 15-Dec-2020.
-
Who acquired Emendo Biotherapeutics?
Emendo Biotherapeutics was acquired by AnGes.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process